|
|
40
|
0012EJ
|
LORATADINE 10MG TAB (KWA/ATB)
|
LORATADINE
|
LORATADINE
|
10X10
|
A
|
5.25
|
0.05
|
TABLET
|
14
|
TAB
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
0408
|
SECOND GENERATION ANTIHISTAMINES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTIHISTAMINICS
|
|
|
|
40
|
0012FD
|
GLENCET 5MG TAB (GLP/ATB) LEVOCETIRIZINE
|
LEVOCETIRIZINE
|
GLENCET
|
30'S
|
C
|
6.80
|
0.23
|
TABLET
|
0
|
TAB
|
GLP
|
GLENMARK PHARMACEUTICALS LTD
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
0408
|
SECOND GENERATION ANTIHISTAMINES
|
2022-04-01
|
2024-03-31
|
Change Local Agent
|
Oral
|
0
|
ANTIHISTAMINICS
|
2022-03-22
|
|
|
41
|
0012FF
|
APO-CETIRIZINE 10MG TAB (APO)
|
CETIRIZINE
|
APO-CETIRIZINE
|
100'S
|
A
|
8.54
|
0.0854
|
TAB
|
14
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
0408
|
SECOND GENERATION ANTIHISTAMINES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
SECOND GENERATION ANTIHISTAMINES
|
|
|
|
40
|
0012VB
|
CETIRIZINE 10MG TAB (HEA/ATB)
|
CETIRIZINE
|
CETIRIZINE
|
1X10
|
A
|
0.95
|
0.095
|
TABLET IMMED
|
|
|
HEA
|
HEALTH 2000 INC
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
408
|
SECOND GENERATION ANTIHISTAMINES
|
2022-12-07
|
2024-03-31
|
Change Local Agent
|
oral
|
0
|
SECOND GENERATION ANTIHISTAMINES
|
2022-11-25
|
|
|
40
|
0013BL
|
DPH ELIXIR 2.5MG/ML SYR (FED/ATB) DIPHENHYDRA
|
DIPHENHYDRAMINE
|
DPH ELIXIR
|
120ML
|
A
|
4.08
|
0.03
|
SYRUP
|
120
|
ML
|
FED
|
FEDERATED PHARMACEUTICAL CO. LT
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
0404
|
FIRST GENERATION ANTIHISTAMINES
|
2022-05-11
|
2024-03-31
|
Change Local Agent
|
Oral
|
6
|
ANTIHISTAMINICS
|
2022-05-11
|
|
|
40
|
0013KA
|
CETIRIZINE 1MG/ML SYR (HEA/ATB)
|
CETIRIZINE
|
CETIRIZINE
|
60ML
|
A
|
2.69
|
0.0448
|
SYRUP
|
|
|
HEA
|
HEALTH 2000 INC
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
408
|
SECOND GENERATION ANTIHISTAMINES
|
2022-12-07
|
2024-03-31
|
Change Local Agent
|
oral
|
0
|
SECOND GENERATION ANTIHISTAMINES
|
2022-11-25
|
|
|
41
|
0013KA
|
CETIRIZINE 1MG/ML SYR (HEA)
|
CETIRIZINE
|
CETIRIZINE
|
60ML
|
A
|
2.91
|
0.0485
|
ML
|
60
|
BOTT
|
HEA
|
HEALTH 2000 INC
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
0408
|
SECOND GENERATION ANTIHISTAMINES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
SECOND GENERATION ANTIHISTAMINES
|
|
|
|
40
|
0013PF
|
LORATADINE 1MG/ML SYRUP (HEA/ATB)
|
LORATADINE
|
LORATADINE
|
100 ML
|
A
|
3.13
|
0.0313
|
SYRUP
|
|
|
HEA
|
HEALTH 2000 INC
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
408
|
SECOND GENERATION ANTIHISTAMINES
|
2022-12-07
|
2024-03-31
|
Change Local Agent
|
ORAL
|
0
|
SECOND GENERATION ANTIHISTAMINES
|
2022-11-25
|
|
|
41
|
0013PF
|
LORATADINE 1MG/ML SYR (HEA)
|
LORATADINE
|
LORATADINE
|
100ML
|
A
|
3.18
|
0.0318
|
ML
|
120
|
BOTT
|
HEA
|
HEALTH 2000 INC
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
0408
|
SECOND GENERATION ANTIHISTAMINES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
SECOND GENERATION ANTIHISTAMINES
|
|
|
|
40
|
0014M
|
CHLORPHENIRAMINE 10MG/ML IV/IM INJ (FSB/ATB)
|
CHLORPHENIRAMINE
|
CHLORPHENIRAMINE
|
10X1ML
|
B
|
4.49
|
0.45
|
INJECTION
|
0
|
AMP
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
0404
|
FIRST GENERATION ANTIHISTAMINES
|
2022-04-01
|
2024-03-31
|
|
IV/IM
|
0
|
ANTIHISTAMINICS
|
|
|
|
41
|
0014M
|
CHLORPHENIRAMINE 10MG/ML IV/IM INJ (FSB) (B)
|
CHLORPHENIRAMINE
|
CHLORPHENIRAMINE
|
10X1ML
|
B
|
3.83
|
0.3833
|
AMP
|
30
|
BOX
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
0404
|
FIRST GENERATION ANTIHISTAMINES
|
2024-04-01
|
2026-03-31
|
|
IV/IM
|
6
|
FIRST GENERATION ANTIHISTAMINES
|
|
|
|
41
|
0071H
|
APO-ZOLPIDEM 5MG TAB (APO) ZOLPIDEM
|
ZOLPIDEM
|
APO-ZOLPIDEM
|
30'S
|
C
|
18.16
|
0.6053
|
TAB
|
0
|
BOX
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
282492
|
ANXIOLYTICS, SEDATIVES AND HYPNOTICS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ANXIOLYTICS, SEDATIVES AND HYPNOTICS MISCEL
|
|
|
|
41
|
0072E
|
APO-ZOLPIDEM 10MG TAB (APO) ZOLPIDE (C)
|
ZOLPIDEM
|
APO-ZOLPIDEM
|
30'S
|
C
|
20.39
|
0.6796
|
TAB
|
0
|
BOX
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
282492
|
ANXIOLYTICS, SEDATIVES AND HYPNOTICS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ANXIOLYTICS, SEDATIVES AND HYPNOTICS MISCEL
|
|
|
|
40
|
0081AJ
|
AMPHIZOME 50MG INJ (FSB/ATB) AMPHOTERICIN B
|
AMPHOTERICIN B
|
AMPHIZOME
|
5ML
|
BQ
|
24.46
|
24.46
|
INJECTION
|
0
|
VIAL
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
081428
|
POLYENES
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
40
|
0102V
|
NYSTATIN 100,000U/ML SUSP (HEA/ATB)
|
NYSTATIN
|
NYSTATIN
|
60ML
|
A
|
5.71
|
0.0952
|
SUSPENSION
|
|
|
HEA
|
HEALTH 2000 INC
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
81428
|
POLYENES
|
2022-12-07
|
2024-03-31
|
Change Local Agent
|
ORAL
|
0
|
POLYENES
|
2022-11-25
|
|
|
41
|
0102V
|
NYSTATIN 100,000U/ML SUSP (HEA)
|
NYSTATIN
|
NYSTATIN
|
60ML
|
A
|
5.76
|
0.096
|
ML
|
180
|
BOTT
|
HEA
|
HEALTH 2000 INC
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
081428
|
POLYENES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
POLYENES
|
|
|
|
40
|
0111D
|
CEFUROXIME 500MG CAP (KWA/ATB)
|
CEFUROXIME
|
CEFUROXIME
|
100'S
|
BQ
|
66.95
|
0.67
|
CAPSULE
|
0
|
CAP
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
40
|
0111DL
|
CEFADROXIL 500MG CAP (KWA/ATB)
|
CEFADROXIL
|
CEFADROXIL
|
10X10
|
A
|
23.11
|
0.23
|
CAPSULE
|
28
|
CAP
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08120604
|
FIRST GEN CEPHALOSPORINS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
40
|
0113AG
|
CEFAZOLIN 1G IV/IM INJ (KWA/ATB)
|
CEFAZOLIN
|
CEFAZOLIN
|
1G VIAL
|
B
|
4.02
|
4.02
|
INJECTION
|
0
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08120604
|
FIRST GEN CEPHALOSPORINS
|
2022-04-01
|
2022-09-30
|
|
IV/IM
|
0
|
ANTI-INFECTIVE AGENTS
|
2022-03-30
|
|
|
40
|
0114BP
|
ALTACEF 250MG TAB (GLP/ATB) CEFUROXIME
|
CEFUROXIME
|
ALTACEF
|
10'S
|
BQ
|
4.08
|
0.41
|
TABLET
|
0
|
TAB
|
GLP
|
GLENMARK PHARMACEUTICALS LTD
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2022-04-01
|
2024-03-31
|
Change Local Agent
|
Oral
|
6
|
ANTI-INFECTIVE AGENTS
|
2022-03-22
|